Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices
•Nonmetropolitan community urology practices present important opportunities to increase cancer clinical trial accrual.•Even in communities with available cancer clinical trials, practices have limited awareness of trials because they lack social connections with trial investigators.•Rural-serving u...
Uloženo v:
| Vydáno v: | Urologic oncology Ročník 37; číslo 8; s. 529.e9 - 529.e18 |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
Elsevier Inc
01.08.2019
|
| Témata: | |
| ISSN: | 1078-1439, 1873-2496, 1873-2496 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | •Nonmetropolitan community urology practices present important opportunities to increase cancer clinical trial accrual.•Even in communities with available cancer clinical trials, practices have limited awareness of trials because they lack social connections with trial investigators.•Rural-serving urologists were motivated to offer trials because they see trials as extending available treatment options, which is aligned with their professional role.•Practices were receptive to interventions, including external facilitation, to help them offer trials to their patients.
Engaging community urologists in referring patients to clinical trials could increase the reach of cancer trials and, ultimately, alleviate cancer disparities. We sought to identify determinants of referring patients to clinical trials among urology practices serving rural communities.
We conducted semistructured qualitative interviews based on the Theoretical Domains Framework at nonmetropolitan urology practices located in communities offering urological cancer trials. Participants were asked to consider barriers and strategies that might support engaging their patients in discussions about urological cancer clinical trials and referring them appropriately. Recorded interviews were transcribed and coded using template analysis.
Most participants were not aware of available trials and had no experience with trial referral. Overall, participants held positive attitudes toward clinical trials and recognized their potential roles in accrual, but limited local resources reduced opportunities for offering trials. Most participants expressed a need for increased human, financial, and other resources to support this role. Many participants requested information and training to increase their knowledge of clinical trials and confidence in offering them to patients. Participants highlighted the need to build efficient pathways to identify available trials, match eligible patients, and facilitate communication and collaboration with cancer centers for patient follow-up and continuity of care.
With adequate logistical and informational support, community urology practices could play an important role in clinical trial accrual, advancing cancer research and increasing treatment options for rural cancer patients. Future studies should explore the effectiveness of strategies to optimize urology practices’ role in clinical trial accrual. |
|---|---|
| AbstractList | Engaging community urologists in referring patients to clinical trials could increase the reach of cancer trials and, ultimately, alleviate cancer disparities. We sought to identify determinants of referring patients to clinical trials among urology practices serving rural communities.
We conducted semistructured qualitative interviews based on the Theoretical Domains Framework at nonmetropolitan urology practices located in communities offering urological cancer trials. Participants were asked to consider barriers and strategies that might support engaging their patients in discussions about urological cancer clinical trials and referring them appropriately. Recorded interviews were transcribed and coded using template analysis.
Most participants were not aware of available trials and had no experience with trial referral. Overall, participants held positive attitudes toward clinical trials and recognized their potential roles in accrual, but limited local resources reduced opportunities for offering trials. Most participants expressed a need for increased human, financial, and other resources to support this role. Many participants requested information and training to increase their knowledge of clinical trials and confidence in offering them to patients. Participants highlighted the need to build efficient pathways to identify available trials, match eligible patients, and facilitate communication and collaboration with cancer centers for patient follow-up and continuity of care.
With adequate logistical and informational support, community urology practices could play an important role in clinical trial accrual, advancing cancer research and increasing treatment options for rural cancer patients. Future studies should explore the effectiveness of strategies to optimize urology practices' role in clinical trial accrual. •Nonmetropolitan community urology practices present important opportunities to increase cancer clinical trial accrual.•Even in communities with available cancer clinical trials, practices have limited awareness of trials because they lack social connections with trial investigators.•Rural-serving urologists were motivated to offer trials because they see trials as extending available treatment options, which is aligned with their professional role.•Practices were receptive to interventions, including external facilitation, to help them offer trials to their patients. Engaging community urologists in referring patients to clinical trials could increase the reach of cancer trials and, ultimately, alleviate cancer disparities. We sought to identify determinants of referring patients to clinical trials among urology practices serving rural communities. We conducted semistructured qualitative interviews based on the Theoretical Domains Framework at nonmetropolitan urology practices located in communities offering urological cancer trials. Participants were asked to consider barriers and strategies that might support engaging their patients in discussions about urological cancer clinical trials and referring them appropriately. Recorded interviews were transcribed and coded using template analysis. Most participants were not aware of available trials and had no experience with trial referral. Overall, participants held positive attitudes toward clinical trials and recognized their potential roles in accrual, but limited local resources reduced opportunities for offering trials. Most participants expressed a need for increased human, financial, and other resources to support this role. Many participants requested information and training to increase their knowledge of clinical trials and confidence in offering them to patients. Participants highlighted the need to build efficient pathways to identify available trials, match eligible patients, and facilitate communication and collaboration with cancer centers for patient follow-up and continuity of care. With adequate logistical and informational support, community urology practices could play an important role in clinical trial accrual, advancing cancer research and increasing treatment options for rural cancer patients. Future studies should explore the effectiveness of strategies to optimize urology practices’ role in clinical trial accrual. Engaging community urologists in referring patients to clinical trials could increase the reach of cancer trials and, ultimately, alleviate cancer disparities. We sought to identify determinants of referring patients to clinical trials among urology practices serving rural communities.OBJECTIVEEngaging community urologists in referring patients to clinical trials could increase the reach of cancer trials and, ultimately, alleviate cancer disparities. We sought to identify determinants of referring patients to clinical trials among urology practices serving rural communities.We conducted semistructured qualitative interviews based on the Theoretical Domains Framework at nonmetropolitan urology practices located in communities offering urological cancer trials. Participants were asked to consider barriers and strategies that might support engaging their patients in discussions about urological cancer clinical trials and referring them appropriately. Recorded interviews were transcribed and coded using template analysis.METHODSWe conducted semistructured qualitative interviews based on the Theoretical Domains Framework at nonmetropolitan urology practices located in communities offering urological cancer trials. Participants were asked to consider barriers and strategies that might support engaging their patients in discussions about urological cancer clinical trials and referring them appropriately. Recorded interviews were transcribed and coded using template analysis.Most participants were not aware of available trials and had no experience with trial referral. Overall, participants held positive attitudes toward clinical trials and recognized their potential roles in accrual, but limited local resources reduced opportunities for offering trials. Most participants expressed a need for increased human, financial, and other resources to support this role. Many participants requested information and training to increase their knowledge of clinical trials and confidence in offering them to patients. Participants highlighted the need to build efficient pathways to identify available trials, match eligible patients, and facilitate communication and collaboration with cancer centers for patient follow-up and continuity of care.RESULTSMost participants were not aware of available trials and had no experience with trial referral. Overall, participants held positive attitudes toward clinical trials and recognized their potential roles in accrual, but limited local resources reduced opportunities for offering trials. Most participants expressed a need for increased human, financial, and other resources to support this role. Many participants requested information and training to increase their knowledge of clinical trials and confidence in offering them to patients. Participants highlighted the need to build efficient pathways to identify available trials, match eligible patients, and facilitate communication and collaboration with cancer centers for patient follow-up and continuity of care.With adequate logistical and informational support, community urology practices could play an important role in clinical trial accrual, advancing cancer research and increasing treatment options for rural cancer patients. Future studies should explore the effectiveness of strategies to optimize urology practices' role in clinical trial accrual.CONCLUSIONSWith adequate logistical and informational support, community urology practices could play an important role in clinical trial accrual, advancing cancer research and increasing treatment options for rural cancer patients. Future studies should explore the effectiveness of strategies to optimize urology practices' role in clinical trial accrual. |
| Author | Brekke, Gayle Mackay, Christine B. Gills, Jessie Thrasher, J. Brantley Griebling, Tomas L. Ellis, Shellie D. Geana, Mugur Moon, Deborah J. Zganjar, Andrew |
| AuthorAffiliation | 6 The Landon Center on Aging, Kansas University Medical Center, Kansas City, KS 5 Department of Urology, University of Kansas School of Medicine, Kansas City, KS 3 University of Kansas Cancer Center, Kansas City, KS 2 School of Journalism and Mass Communications, University of Kansas, Lawrence, KS 4 Department of Urology, Louisiana State University, New Orleans, LA 1 Department of Health Policy & Management, University of Kansas School of Medicine, Kansas City, KS |
| AuthorAffiliation_xml | – name: 1 Department of Health Policy & Management, University of Kansas School of Medicine, Kansas City, KS – name: 5 Department of Urology, University of Kansas School of Medicine, Kansas City, KS – name: 2 School of Journalism and Mass Communications, University of Kansas, Lawrence, KS – name: 3 University of Kansas Cancer Center, Kansas City, KS – name: 6 The Landon Center on Aging, Kansas University Medical Center, Kansas City, KS – name: 4 Department of Urology, Louisiana State University, New Orleans, LA |
| Author_xml | – sequence: 1 givenname: Shellie D. orcidid: 0000-0002-3599-0804 surname: Ellis fullname: Ellis, Shellie D. email: Sellis4@kumc.edu organization: Department of Health Policy & Management, University of Kansas School of Medicine, Kansas City, KS – sequence: 2 givenname: Mugur surname: Geana fullname: Geana, Mugur organization: School of Journalism and Mass Communications, University of Kansas, Lawrence, KS – sequence: 3 givenname: Christine B. surname: Mackay fullname: Mackay, Christine B. organization: Department of Health Policy & Management, University of Kansas School of Medicine, Kansas City, KS – sequence: 4 givenname: Deborah J. surname: Moon fullname: Moon, Deborah J. organization: Department of Health Policy & Management, University of Kansas School of Medicine, Kansas City, KS – sequence: 5 givenname: Jessie surname: Gills fullname: Gills, Jessie organization: Department of Urology, Louisiana State University, New Orleans, LA – sequence: 6 givenname: Andrew surname: Zganjar fullname: Zganjar, Andrew organization: Department of Urology, University of Kansas School of Medicine, Kansas City, KS – sequence: 7 givenname: Gayle surname: Brekke fullname: Brekke, Gayle organization: Department of Health Policy & Management, University of Kansas School of Medicine, Kansas City, KS – sequence: 8 givenname: J. Brantley surname: Thrasher fullname: Thrasher, J. Brantley organization: Department of Urology, University of Kansas School of Medicine, Kansas City, KS – sequence: 9 givenname: Tomas L. surname: Griebling fullname: Griebling, Tomas L. organization: Department of Urology, University of Kansas School of Medicine, Kansas City, KS |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30935846$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUUtv1DAQtlARfcBPAPnIJcFOHCcBUYSqQpEqcQDOlteebL049mI7K_bGT8fZB4JeijSSR5rvMZ7vHJ047wCh55SUlFD-alVOwVvvVFkR2pekLglhj9AZ7dq6qFjPT3JP2q6grO5P0XmMK0Io6yh9gk5r0tdNx_gZ-vVFGXAKsHE43QG-ARmSlU6_xtc_19YH45ZYQ4IwGidditgPuQbYDZTM1ICVNc4oaXEKRto4a4UpSFtECJsdzo_j5Eza4t3Syy1eB6mSURCfosdD5sCzw3uBvn24_np1U9x-_vjp6v1toZqKpqIHzRaybxXjkjatbiRTbVPJdqBVxZtmwfOXOs6Y7ga-0FqT3CnJa0mpBCXrC3S5111PixG0ApfyhmIdzCjDVnhpxL8TZ-7E0m8E55zSrskCLw8Cwf-YICYxmqjA5mOBn6KoKjJX38_QF397_TE5nj0D3uwBKvgYAwxCmSST8bO1sYISMYcsVuIQsphDFqQWOeTMbu6xjwYP8d7teZDvvDEQRNyHr00AlYT25kGFt_cUjtF_h-1_8H8D7kneAQ |
| CitedBy_id | crossref_primary_10_1186_s12961_023_01030_5 crossref_primary_10_1186_s13063_019_3658_z crossref_primary_10_1245_s10434_021_11304_3 crossref_primary_10_1016_j_jclinepi_2020_12_013 crossref_primary_10_1177_17407745221090733 crossref_primary_10_1186_s43058_020_00064_y crossref_primary_10_1080_08998280_2025_2547162 crossref_primary_10_1016_j_conctc_2022_100981 crossref_primary_10_1186_s13063_022_06816_6 crossref_primary_10_1371_journal_pone_0255578 crossref_primary_10_1093_jncics_pkac017 crossref_primary_10_3389_fneur_2024_1419867 crossref_primary_10_1136_jme_2024_109867 |
| Cites_doi | 10.1200/JCO.18.01132 10.1016/j.cct.2007.04.004 10.1111/iju.13325 10.1001/jama.2018.0154 10.1016/j.conctc.2016.12.004 10.1200/JCO.2007.14.6027 10.1200/JCO.2012.45.4553 10.1200/JCO.2002.08.056 10.15585/mmwr.ss6614a1 10.1016/S0895-4356(99)00141-9 10.1136/qshc.2004.011155 10.1016/j.cct.2014.12.010 10.1001/jama.289.22.2970 10.1634/theoncologist.2015-0068 10.1200/JCO.2011.39.5186 10.1200/JOP.18.00120 10.1634/theoncologist.2015-0481 10.1634/theoncologist.2017-0628 10.2147/AMEP.S14103 10.1200/JOP.2013.001311 10.1200/JCO.2003.02.105 10.1186/s13012-017-0605-9 10.1016/j.urology.2007.03.019 10.1016/j.jclinepi.2013.08.007 10.1001/jamaoncol.2017.3598 10.1001/jamaoncol.2017.5694 10.1089/jpm.2012.0413 10.1016/j.urolonc.2017.12.019 10.1177/1740774514536000 10.1158/1055-9965.EPI-17-0092 10.1007/s12160-013-9486-6 10.1186/1748-5908-7-38 10.1186/s13012-014-0167-z |
| ContentType | Journal Article |
| Copyright | 2019 Elsevier Inc. Copyright © 2019 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2019 Elsevier Inc. – notice: Copyright © 2019 Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION NPM 7X8 5PM |
| DOI | 10.1016/j.urolonc.2019.03.004 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1873-2496 |
| EndPage | 529.e18 |
| ExternalDocumentID | PMC6661185 30935846 10_1016_j_urolonc_2019_03_004 S1078143919300973 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: Mentored Training in Dissemination and Implementation Research in Cancer grantid: R25 CA171994 – fundername: NCI NIH HHS grantid: R25 CA171994 |
| GroupedDBID | --- --K --M -RU .1- .FO .~1 0R~ 123 1B1 1P~ 1~. 1~5 29Q 4.4 457 4CK 4G. 53G 5RE 5VS 6PF 7-5 71M 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACLOT ACRLP ACRPL ADBBV ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AEVXI AFJKZ AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OK. OW. OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SDF SDG SEL SES SEW SSH SSZ T5K UDS UHS Z5R ZGI ~G- ~HD AACTN AAIAV ABLVK ABYKQ AFKWA AJBFU AJOXV AMFUW LCYCR RIG 9DU AAYXX CITATION NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c521t-9ed4ba97c46a157d5a4c752a7f122655b60938644d8f6bddd04d8ca63a11aeca3 |
| ISICitedReferencesCount | 12 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000476867800004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1078-1439 1873-2496 |
| IngestDate | Tue Sep 30 16:32:24 EDT 2025 Sun Nov 09 10:35:19 EST 2025 Thu Apr 03 07:08:07 EDT 2025 Tue Nov 18 22:40:04 EST 2025 Sat Nov 29 07:02:31 EST 2025 Fri Feb 23 02:13:27 EST 2024 Tue Oct 14 19:33:15 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | Community practice Clinical trials Urological cancer Implementation science Cancer care delivery Physician recommendation |
| Language | English |
| License | Copyright © 2019 Elsevier Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c521t-9ed4ba97c46a157d5a4c752a7f122655b60938644d8f6bddd04d8ca63a11aeca3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-3599-0804 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/6661185 |
| PMID | 30935846 |
| PQID | 2202202995 |
| PQPubID | 23479 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6661185 proquest_miscellaneous_2202202995 pubmed_primary_30935846 crossref_citationtrail_10_1016_j_urolonc_2019_03_004 crossref_primary_10_1016_j_urolonc_2019_03_004 elsevier_sciencedirect_doi_10_1016_j_urolonc_2019_03_004 elsevier_clinicalkey_doi_10_1016_j_urolonc_2019_03_004 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-08-01 |
| PublicationDateYYYYMMDD | 2019-08-01 |
| PublicationDate_xml | – month: 08 year: 2019 text: 2019-08-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Urologic oncology |
| PublicationTitleAlternate | Urol Oncol |
| PublicationYear | 2019 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Geana, Erba, Krebill (bib0036) 2017; 5 Martin, Donovan, Turner (bib0002) 2018; 319 Williams, Maher, Hancock, McAuley, Lin, Latimer (bib0047) 2014; 67 (bib0007) 2016 [computer program]. USA. Department of Health and Human Services, Center for Disease Control and Prevention and National Cancer Institute; 2017. Michie, Richardson, Johnston (bib0048) 2013; 46 Ciprut, Sedlander, Watts (bib0032) 2018; 36 Jacobsen, Wells, Meade (bib0046) 2012; 30 Zullig, Fortune-Britt, Rao, Tyree, Godley, Carpenter (bib0014) 2016; 77 Taguchi, Fukuhara, Homma, Todo (bib0001) 2017; 24 Birken, Presseau, Ellis, Gerstel, Mayer (bib0031) 2014; 9 Kirkwood, Bruinooge, Goldstein, Bajorin, Kosty (bib0021) 2014; 10 Goldman, Berry, McCabe (bib0042) 2003; 289 Jimenez, Zhang, Joffe (bib0010) 2013; 16 Baquet, Ellison, Mishra (bib0013) 2008; 26 Jacobs, Weiner, Reeve, Weinberger, Minasian, Good (bib0025) 2014; 11 (bib0008) 2017 (bib0004) 2018 Creswell (bib0033) 2014 Symon, Cassell (bib0030) 1998 Leech, Dusetzina (bib0041) 2018 (bib0016) 2018 Comis, Miller, Aldigé, Krebs, Stoval (bib0012) 2003; 21 Dusetzina, Huskamp, Winn, Basch, Keating (bib0039) 2018; 4 (bib0009) 2018 Sateren, Trimble, Abrams (bib0049) 2002; 20 French, Green, O'Connor (bib0050) 2012; 7 Rahman, Majumder, Shaban (bib0035) 2011; 2 Sateren, Trimble, Abrams (bib0015) 2002; 20 Nipp, Lee, Powell (bib0044) 2016; 21 Ross, Grant, Counsell, Gillespie, Russell, Prescott (bib0034) 1999; 52 Unger, Moseley, Symington, Chavez-MacGregor, Ramsey, Hershman (bib0020) 2018; 36 Unger, Hershman, Albain (bib0037) 2013; 31 (bib0005) 2018 Winkfield, Phillips, Joffe, Halpern, Wollins, Moy (bib0038) 2018 Borno, Zhang, Siegel, Chang, Ryan (bib0028) 2018; 23 Atkins, Francis, Islam (bib0027) 2017; 12 Tanner, Kim, Friedman, Foster, Bergeron (bib0011) 2015; 41 Kilgore, Goldman (bib0043) 2008; 29 (bib0003) 2018 [computer program]. 55 Cambridge Street Burlington, MA 01803 USA: QSR International Pty Ltd; 2015. Blake, Moss, Gaysynsky, Srinivasan, Croyle (bib0018) 2017; 26 Nipp, Powell, Chabner, Moy (bib0045) 2015; 20 Michie, Johnston, Abraham (bib0026) 2005; 14 Swanson, Carpenter, Thompson, Crawford (bib0024) 2007; 70 Knight, Deal, Dusetzina (bib0040) 2018 Henley, Anderson, Thomas, Massetti, Peaker, Richardson (bib0019) 2017; 66 (bib0023) 2017 (bib0006) 2018 Martinez, Paskett (bib0017) 2018; 4 (10.1016/j.urolonc.2019.03.004_bib0003) 2018 Michie (10.1016/j.urolonc.2019.03.004_bib0026) 2005; 14 Dusetzina (10.1016/j.urolonc.2019.03.004_bib0039) 2018; 4 Blake (10.1016/j.urolonc.2019.03.004_bib0018) 2017; 26 Taguchi (10.1016/j.urolonc.2019.03.004_bib0001) 2017; 24 Michie (10.1016/j.urolonc.2019.03.004_bib0048) 2013; 46 Martinez (10.1016/j.urolonc.2019.03.004_bib0017) 2018; 4 Williams (10.1016/j.urolonc.2019.03.004_bib0047) 2014; 67 Unger (10.1016/j.urolonc.2019.03.004_bib0020) 2018; 36 Tanner (10.1016/j.urolonc.2019.03.004_bib0011) 2015; 41 Unger (10.1016/j.urolonc.2019.03.004_bib0037) 2013; 31 (10.1016/j.urolonc.2019.03.004_bib0007) 2016 Knight (10.1016/j.urolonc.2019.03.004_bib0040) 2018 Henley (10.1016/j.urolonc.2019.03.004_bib0019) 2017; 66 Jimenez (10.1016/j.urolonc.2019.03.004_bib0010) 2013; 16 Zullig (10.1016/j.urolonc.2019.03.004_bib0014) 2016; 77 Winkfield (10.1016/j.urolonc.2019.03.004_bib0038) 2018 Baquet (10.1016/j.urolonc.2019.03.004_bib0013) 2008; 26 (10.1016/j.urolonc.2019.03.004_bib0004) 2018 Geana (10.1016/j.urolonc.2019.03.004_bib0036) 2017; 5 Sateren (10.1016/j.urolonc.2019.03.004_bib0049) 2002; 20 Ross (10.1016/j.urolonc.2019.03.004_bib0034) 1999; 52 Goldman (10.1016/j.urolonc.2019.03.004_bib0042) 2003; 289 (10.1016/j.urolonc.2019.03.004_bib0016) 2018 Atkins (10.1016/j.urolonc.2019.03.004_bib0027) 2017; 12 Kirkwood (10.1016/j.urolonc.2019.03.004_bib0021) 2014; 10 French (10.1016/j.urolonc.2019.03.004_bib0050) 2012; 7 Rahman (10.1016/j.urolonc.2019.03.004_bib0035) 2011; 2 (10.1016/j.urolonc.2019.03.004_bib0008) 2017 Jacobsen (10.1016/j.urolonc.2019.03.004_bib0046) 2012; 30 Nipp (10.1016/j.urolonc.2019.03.004_bib0044) 2016; 21 Creswell (10.1016/j.urolonc.2019.03.004_bib0033) 2014 Comis (10.1016/j.urolonc.2019.03.004_bib0012) 2003; 21 (10.1016/j.urolonc.2019.03.004_bib0005) 2018 Leech (10.1016/j.urolonc.2019.03.004_bib0041) 2018 Martin (10.1016/j.urolonc.2019.03.004_bib0002) 2018; 319 Birken (10.1016/j.urolonc.2019.03.004_bib0031) 2014; 9 Nipp (10.1016/j.urolonc.2019.03.004_bib0045) 2015; 20 (10.1016/j.urolonc.2019.03.004_bib0009) 2018 10.1016/j.urolonc.2019.03.004_bib0029 Sateren (10.1016/j.urolonc.2019.03.004_bib0015) 2002; 20 Symon (10.1016/j.urolonc.2019.03.004_bib0030) 1998 Borno (10.1016/j.urolonc.2019.03.004_bib0028) 2018; 23 Jacobs (10.1016/j.urolonc.2019.03.004_bib0025) 2014; 11 (10.1016/j.urolonc.2019.03.004_bib0006) 2018 Kilgore (10.1016/j.urolonc.2019.03.004_bib0043) 2008; 29 10.1016/j.urolonc.2019.03.004_bib0022 Swanson (10.1016/j.urolonc.2019.03.004_bib0024) 2007; 70 (10.1016/j.urolonc.2019.03.004_bib0023) 2017 Ciprut (10.1016/j.urolonc.2019.03.004_bib0032) 2018; 36 |
| References_xml | – reference: [computer program]. 55 Cambridge Street Burlington, MA 01803 USA: QSR International Pty Ltd; 2015. – volume: 20 start-page: 2109 year: 2002 end-page: 2117 ident: bib0015 article-title: How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials publication-title: J Clin Oncol – volume: 289 start-page: 2970 year: 2003 end-page: 2977 ident: bib0042 article-title: Incremental treatment costs in National Cancer Institute-sponsored clinical trials publication-title: JAMA – volume: 319 start-page: 883 year: 2018 end-page: 895 ident: bib0002 article-title: Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial publication-title: JAMA – volume: 4 year: 2018 ident: bib0039 article-title: Out-of-pocket and health care spending changes for patients using orally administered anticancer therapy after adoption of state parity laws publication-title: JAMA Oncol – volume: 46 start-page: 81 year: 2013 end-page: 95 ident: bib0048 article-title: The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions publication-title: Ann Behav Med – volume: 2 start-page: 85 year: 2011 end-page: 93 ident: bib0035 article-title: Physician participation in clinical research and trials: issues and approaches publication-title: Adv Med Educ Pract – year: 2018 ident: bib0040 article-title: Financial toxicity in adults with cancer: adverse outcomes and noncompliance publication-title: J Oncol Pract – volume: 77 start-page: 52 year: 2016 end-page: 58 ident: bib0014 article-title: Enrollment and racial disparities in cancer treatment clinical trials in North Carolina publication-title: N C Med J – volume: 20 start-page: 572 year: 2015 end-page: 575 ident: bib0045 article-title: Recognizing the financial burden of cancer patients in clinical trials publication-title: Oncologist – year: 2018 ident: bib0006 article-title: NCCN clinical practice guidelines in oncology (NCCN guidelines): bladder cancer – year: 2017 ident: bib0023 article-title: The state of the urology workforce and practice in the United States 2016 – volume: 11 start-page: 565 year: 2014 end-page: 575 ident: bib0025 article-title: Organizational and physician factors associated with patient enrollment in cancer clinical trials publication-title: Clin Trials – volume: 21 start-page: 830 year: 2003 end-page: 835 ident: bib0012 article-title: Public attitudes toward participation in cancer clinical trials publication-title: J Clin Oncol – volume: 26 start-page: 3380 year: 2008 end-page: 3386 ident: bib0013 article-title: Analysis of Maryland cancer patient participation in national cancer institute-supported cancer treatment clinical trials publication-title: J Clin Oncol – volume: 70 start-page: 19 year: 2007 end-page: 24 ident: bib0024 article-title: Urologists’ attitudes regarding cancer clinical research publication-title: Urology – volume: 30 start-page: 2516 year: 2012 ident: bib0046 article-title: Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial publication-title: J Clin Oncol – volume: 29 start-page: 1 year: 2008 end-page: 8 ident: bib0043 article-title: Drug costs and out-of-pocket spending in cancer clinical trials publication-title: Contemp Clin Trials – volume: 23 start-page: 1242 year: 2018 end-page: 1249 ident: bib0028 article-title: At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials publication-title: Oncologist – volume: 41 start-page: 39 year: 2015 end-page: 44 ident: bib0011 article-title: Promoting clinical research to medically underserved communities: current practices and perceptions about clinical trial recruiting strategies publication-title: Contemp Clin Trials – volume: 21 start-page: 467 year: 2016 end-page: 474 ident: bib0044 article-title: Financial burden of cancer clinical trial participation and the impact of a cancer care equity program publication-title: Oncologist – volume: 31 start-page: 536 year: 2013 ident: bib0037 article-title: Patient income level and cancer clinical trial participation publication-title: J Clin Oncol – volume: 12 start-page: 77 year: 2017 ident: bib0027 article-title: A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems publication-title: Implement Sci – year: 2018 ident: bib0041 article-title: Cost-effective but unaffordable: the CAR-T conundrum publication-title: J Natl Cancer Inst – volume: 26 start-page: 992 year: 2017 end-page: 997 ident: bib0018 article-title: Making the case for investment in rural cancer control: an analysis of rural cancer incidence, mortality, and funding trends publication-title: Cancer Epidemiol Prev Biomark – volume: 36 start-page: 246 year: 2018 end-page: 251 ident: bib0032 article-title: Designing a theory-based intervention to improve the guideline-concordant use of imaging to stage incident prostate cancer publication-title: Urol Oncol – volume: 16 start-page: 256 year: 2013 end-page: 262 ident: bib0010 article-title: Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment? publication-title: J Palliat Med – volume: 52 start-page: 1143 year: 1999 end-page: 1156 ident: bib0034 article-title: Barriers to participation in randomised controlled trials: a systematic review publication-title: J Clin Epidemiol – year: 2018 ident: bib0016 article-title: Research emphasis – volume: 7 start-page: 38 year: 2012 ident: bib0050 article-title: Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the Theoretical Domains Framework publication-title: Implement Sci – volume: 9 start-page: 167 year: 2014 ident: bib0031 article-title: Potential determinants of health-care professionals' use of survivorship care plans: a qualitative study using the theoretical domains framework publication-title: Implement Sci – reference: : [computer program]. USA. Department of Health and Human Services, Center for Disease Control and Prevention and National Cancer Institute; 2017. – year: 2018 ident: bib0004 article-title: NCCN clinical practice guidelines in oncology (NCCN guidelines): kidney cancer – volume: 10 start-page: 32 year: 2014 end-page: 38 ident: bib0021 article-title: Enhancing the American Society of Clinical Oncology workforce information system with geographic distribution of oncologists and comparison of data sources for the number of practicing oncologists publication-title: J Oncol Pract – year: 1998 ident: bib0030 article-title: Qualitative methods and analysis in organizational research: a practical guide – year: 2018 ident: bib0005 article-title: NCCN clinical practice guidelines in oncology (NCCN guidelines): prostate cancer – volume: 66 start-page: 1 year: 2017 end-page: 13 ident: bib0019 article-title: Invasive cancer incidence, 2004-2013, and deaths, 2006-2015, in nonmetropolitan and metropolitan counties – United States publication-title: MMWR Surveill Summ – year: 2014 ident: bib0033 article-title: Research design: qualitative, quantitative and mixed methods approaches – volume: 14 start-page: 26 year: 2005 end-page: 33 ident: bib0026 article-title: Making psychological theory useful for implementing evidence based practice: a consensus approach publication-title: Qual Saf Health Care – volume: 4 start-page: 624 year: 2018 end-page: 625 ident: bib0017 article-title: Using the cancer moonshot to conquer cancer disparities: a model for action publication-title: JAMA Oncol – volume: 20 start-page: 2109 year: 2002 end-page: 2117 ident: bib0049 article-title: How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials publication-title: J Clin Oncol – year: 2018 ident: bib0009 article-title: Barriers to patient enrollment in therapeutic clinical trials for cancer: a landscape report – volume: 24 start-page: 342 year: 2017 end-page: 351 ident: bib0001 article-title: Current status of clinical trials assessing oncolytic virus therapy for urological cancers publication-title: Int J Urol – volume: 36 start-page: e181235 year: 2018 ident: bib0020 article-title: Geographic distribution and survival outcomes for rural cancer patients treated in clinical trials publication-title: J Clin Oncol – volume: 5 start-page: 72 year: 2017 end-page: 79 ident: bib0036 article-title: Searching for cures: Inner-city and rural patients' awareness and perceptions of cancer clinical trials publication-title: Contemp Clin Trials Commun – volume: 67 start-page: 169 year: 2014 end-page: 175 ident: bib0047 article-title: Recruitment rate for a clinical trial was associated with particular operational procedures and clinician characteristics publication-title: J Clin Epidemiol – year: 2018 ident: bib0038 article-title: Addressing financial barriers to patient participation in clinical trials: ASCO policy statement publication-title: J Clin Oncol – year: 2018 ident: bib0003 article-title: NCCN clinical practice guidelines in oncology (NCCN guidelines): testicular cancer – year: 2017 ident: bib0008 article-title: Clinically localized prostate cancer: AUA/ASTRO/SUO guideline – year: 2016 ident: bib0007 article-title: Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO joint guideline – year: 2018 ident: 10.1016/j.urolonc.2019.03.004_bib0038 article-title: Addressing financial barriers to patient participation in clinical trials: ASCO policy statement publication-title: J Clin Oncol doi: 10.1200/JCO.18.01132 – volume: 29 start-page: 1 issue: 1 year: 2008 ident: 10.1016/j.urolonc.2019.03.004_bib0043 article-title: Drug costs and out-of-pocket spending in cancer clinical trials publication-title: Contemp Clin Trials doi: 10.1016/j.cct.2007.04.004 – ident: 10.1016/j.urolonc.2019.03.004_bib0022 – volume: 24 start-page: 342 issue: 5 year: 2017 ident: 10.1016/j.urolonc.2019.03.004_bib0001 article-title: Current status of clinical trials assessing oncolytic virus therapy for urological cancers publication-title: Int J Urol doi: 10.1111/iju.13325 – year: 2017 ident: 10.1016/j.urolonc.2019.03.004_bib0008 – volume: 319 start-page: 883 issue: 9 year: 2018 ident: 10.1016/j.urolonc.2019.03.004_bib0002 article-title: Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2018.0154 – volume: 5 start-page: 72 year: 2017 ident: 10.1016/j.urolonc.2019.03.004_bib0036 article-title: Searching for cures: Inner-city and rural patients' awareness and perceptions of cancer clinical trials publication-title: Contemp Clin Trials Commun doi: 10.1016/j.conctc.2016.12.004 – volume: 26 start-page: 3380 issue: 20 year: 2008 ident: 10.1016/j.urolonc.2019.03.004_bib0013 article-title: Analysis of Maryland cancer patient participation in national cancer institute-supported cancer treatment clinical trials publication-title: J Clin Oncol doi: 10.1200/JCO.2007.14.6027 – year: 2018 ident: 10.1016/j.urolonc.2019.03.004_bib0005 – volume: 31 start-page: 536 issue: 5 year: 2013 ident: 10.1016/j.urolonc.2019.03.004_bib0037 article-title: Patient income level and cancer clinical trial participation publication-title: J Clin Oncol doi: 10.1200/JCO.2012.45.4553 – year: 2018 ident: 10.1016/j.urolonc.2019.03.004_bib0041 article-title: Cost-effective but unaffordable: the CAR-T conundrum publication-title: J Natl Cancer Inst – year: 2018 ident: 10.1016/j.urolonc.2019.03.004_bib0009 – volume: 36 start-page: e181235 issue: 15 year: 2018 ident: 10.1016/j.urolonc.2019.03.004_bib0020 article-title: Geographic distribution and survival outcomes for rural cancer patients treated in clinical trials publication-title: J Clin Oncol – volume: 20 start-page: 2109 issue: 8 year: 2002 ident: 10.1016/j.urolonc.2019.03.004_bib0015 article-title: How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials publication-title: J Clin Oncol doi: 10.1200/JCO.2002.08.056 – volume: 66 start-page: 1 issue: 14 year: 2017 ident: 10.1016/j.urolonc.2019.03.004_bib0019 article-title: Invasive cancer incidence, 2004-2013, and deaths, 2006-2015, in nonmetropolitan and metropolitan counties – United States publication-title: MMWR Surveill Summ doi: 10.15585/mmwr.ss6614a1 – volume: 52 start-page: 1143 issue: 12 year: 1999 ident: 10.1016/j.urolonc.2019.03.004_bib0034 article-title: Barriers to participation in randomised controlled trials: a systematic review publication-title: J Clin Epidemiol doi: 10.1016/S0895-4356(99)00141-9 – year: 2018 ident: 10.1016/j.urolonc.2019.03.004_bib0004 – year: 2017 ident: 10.1016/j.urolonc.2019.03.004_bib0023 – volume: 14 start-page: 26 issue: 1 year: 2005 ident: 10.1016/j.urolonc.2019.03.004_bib0026 article-title: Making psychological theory useful for implementing evidence based practice: a consensus approach publication-title: Qual Saf Health Care doi: 10.1136/qshc.2004.011155 – year: 2018 ident: 10.1016/j.urolonc.2019.03.004_bib0003 – volume: 41 start-page: 39 year: 2015 ident: 10.1016/j.urolonc.2019.03.004_bib0011 article-title: Promoting clinical research to medically underserved communities: current practices and perceptions about clinical trial recruiting strategies publication-title: Contemp Clin Trials doi: 10.1016/j.cct.2014.12.010 – volume: 289 start-page: 2970 issue: 22 year: 2003 ident: 10.1016/j.urolonc.2019.03.004_bib0042 article-title: Incremental treatment costs in National Cancer Institute-sponsored clinical trials publication-title: JAMA doi: 10.1001/jama.289.22.2970 – year: 2018 ident: 10.1016/j.urolonc.2019.03.004_bib0016 – year: 2014 ident: 10.1016/j.urolonc.2019.03.004_bib0033 – volume: 20 start-page: 572 issue: 6 year: 2015 ident: 10.1016/j.urolonc.2019.03.004_bib0045 article-title: Recognizing the financial burden of cancer patients in clinical trials publication-title: Oncologist doi: 10.1634/theoncologist.2015-0068 – volume: 30 start-page: 2516 issue: 20 year: 2012 ident: 10.1016/j.urolonc.2019.03.004_bib0046 article-title: Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial publication-title: J Clin Oncol doi: 10.1200/JCO.2011.39.5186 – year: 2018 ident: 10.1016/j.urolonc.2019.03.004_bib0040 article-title: Financial toxicity in adults with cancer: adverse outcomes and noncompliance publication-title: J Oncol Pract doi: 10.1200/JOP.18.00120 – volume: 21 start-page: 467 issue: 4 year: 2016 ident: 10.1016/j.urolonc.2019.03.004_bib0044 article-title: Financial burden of cancer clinical trial participation and the impact of a cancer care equity program publication-title: Oncologist doi: 10.1634/theoncologist.2015-0481 – volume: 23 start-page: 1242 issue: 10 year: 2018 ident: 10.1016/j.urolonc.2019.03.004_bib0028 article-title: At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials publication-title: Oncologist doi: 10.1634/theoncologist.2017-0628 – volume: 2 start-page: 85 year: 2011 ident: 10.1016/j.urolonc.2019.03.004_bib0035 article-title: Physician participation in clinical research and trials: issues and approaches publication-title: Adv Med Educ Pract doi: 10.2147/AMEP.S14103 – volume: 10 start-page: 32 issue: 1 year: 2014 ident: 10.1016/j.urolonc.2019.03.004_bib0021 article-title: Enhancing the American Society of Clinical Oncology workforce information system with geographic distribution of oncologists and comparison of data sources for the number of practicing oncologists publication-title: J Oncol Pract doi: 10.1200/JOP.2013.001311 – year: 2016 ident: 10.1016/j.urolonc.2019.03.004_bib0007 – volume: 21 start-page: 830 issue: 5 year: 2003 ident: 10.1016/j.urolonc.2019.03.004_bib0012 article-title: Public attitudes toward participation in cancer clinical trials publication-title: J Clin Oncol doi: 10.1200/JCO.2003.02.105 – volume: 12 start-page: 77 issue: 1 year: 2017 ident: 10.1016/j.urolonc.2019.03.004_bib0027 article-title: A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems publication-title: Implement Sci doi: 10.1186/s13012-017-0605-9 – year: 1998 ident: 10.1016/j.urolonc.2019.03.004_bib0030 – year: 2018 ident: 10.1016/j.urolonc.2019.03.004_bib0006 – volume: 70 start-page: 19 issue: 1 year: 2007 ident: 10.1016/j.urolonc.2019.03.004_bib0024 article-title: Urologists’ attitudes regarding cancer clinical research publication-title: Urology doi: 10.1016/j.urology.2007.03.019 – volume: 67 start-page: 169 issue: 2 year: 2014 ident: 10.1016/j.urolonc.2019.03.004_bib0047 article-title: Recruitment rate for a clinical trial was associated with particular operational procedures and clinician characteristics publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2013.08.007 – volume: 4 issue: 6 year: 2018 ident: 10.1016/j.urolonc.2019.03.004_bib0039 article-title: Out-of-pocket and health care spending changes for patients using orally administered anticancer therapy after adoption of state parity laws publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2017.3598 – volume: 4 start-page: 624 issue: 5 year: 2018 ident: 10.1016/j.urolonc.2019.03.004_bib0017 article-title: Using the cancer moonshot to conquer cancer disparities: a model for action publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2017.5694 – volume: 77 start-page: 52 issue: 1 year: 2016 ident: 10.1016/j.urolonc.2019.03.004_bib0014 article-title: Enrollment and racial disparities in cancer treatment clinical trials in North Carolina publication-title: N C Med J – volume: 16 start-page: 256 issue: 3 year: 2013 ident: 10.1016/j.urolonc.2019.03.004_bib0010 article-title: Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment? publication-title: J Palliat Med doi: 10.1089/jpm.2012.0413 – ident: 10.1016/j.urolonc.2019.03.004_bib0029 – volume: 36 start-page: 246 issue: 5 year: 2018 ident: 10.1016/j.urolonc.2019.03.004_bib0032 article-title: Designing a theory-based intervention to improve the guideline-concordant use of imaging to stage incident prostate cancer publication-title: Urol Oncol doi: 10.1016/j.urolonc.2017.12.019 – volume: 11 start-page: 565 issue: 5 year: 2014 ident: 10.1016/j.urolonc.2019.03.004_bib0025 article-title: Organizational and physician factors associated with patient enrollment in cancer clinical trials publication-title: Clin Trials doi: 10.1177/1740774514536000 – volume: 26 start-page: 992 issue: 7 year: 2017 ident: 10.1016/j.urolonc.2019.03.004_bib0018 article-title: Making the case for investment in rural cancer control: an analysis of rural cancer incidence, mortality, and funding trends publication-title: Cancer Epidemiol Prev Biomark doi: 10.1158/1055-9965.EPI-17-0092 – volume: 46 start-page: 81 issue: 1 year: 2013 ident: 10.1016/j.urolonc.2019.03.004_bib0048 article-title: The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions publication-title: Ann Behav Med doi: 10.1007/s12160-013-9486-6 – volume: 20 start-page: 2109 issue: 8 year: 2002 ident: 10.1016/j.urolonc.2019.03.004_bib0049 article-title: How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials publication-title: J Clin Oncol doi: 10.1200/JCO.2002.08.056 – volume: 7 start-page: 38 year: 2012 ident: 10.1016/j.urolonc.2019.03.004_bib0050 article-title: Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the Theoretical Domains Framework publication-title: Implement Sci doi: 10.1186/1748-5908-7-38 – volume: 9 start-page: 167 issue: 1 year: 2014 ident: 10.1016/j.urolonc.2019.03.004_bib0031 article-title: Potential determinants of health-care professionals' use of survivorship care plans: a qualitative study using the theoretical domains framework publication-title: Implement Sci doi: 10.1186/s13012-014-0167-z |
| SSID | ssj0014811 |
| Score | 2.305983 |
| Snippet | •Nonmetropolitan community urology practices present important opportunities to increase cancer clinical trial accrual.•Even in communities with available... Engaging community urologists in referring patients to clinical trials could increase the reach of cancer trials and, ultimately, alleviate cancer disparities.... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 529.e9 |
| SubjectTerms | Cancer care delivery Clinical trials Community practice Implementation science Physician recommendation Urological cancer |
| Title | Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1078143919300973 https://dx.doi.org/10.1016/j.urolonc.2019.03.004 https://www.ncbi.nlm.nih.gov/pubmed/30935846 https://www.proquest.com/docview/2202202995 https://pubmed.ncbi.nlm.nih.gov/PMC6661185 |
| Volume | 37 |
| WOSCitedRecordID | wos000476867800004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1873-2496 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0014811 issn: 1078-1439 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6DU17Qdwpl8lIvFUJS-LEDm9jDI2JTpPYUN8iJ06gYyRV2k7jjX_IX-L42rQDbSDxEkVuTlL7fD4X-5xjhF6SJIkFmMUeKDvhEUoSL6Ul83IeiLwKQ1aoHfxPH-jRERuN0uNe76fNhbk4p3XNLi_TyX9lNbQBs2Xq7F-w270UGuAemA5XYDtcb8R4O1tNAOMB9G-mwhfB919E3ImVMJhGnpOiEnAlDNpFxqQ61kMFzbayQocnV3FNoq7MLAEbft7qOk424WraNXhPWy1dB01dLK3gy2ARhaGPMhR1XA7e-i4WqOQ6U204_zx3wcNDXnzl3xcFEaR5_MbRDJumKz8Hh353PUOmUDG7nqFF8I70a4kuceSXuo3RyANHMenKbV0sxuCTdYRwHKZ-mXZUumrQYv6KxtCLF2e-GqtaFrUMTNlb0n0eeDT5phCjt47JSv1uZREcD_cA9uCyxWtoI6RxCmJ2Y_f9_ujQbWwRpo6Edp1cJJW9-u1_2EKb9oN_spyuekarAb4di-nkDrptXB28qyF6F_XK-h7aHJpgjvvoh0EqHtcYkIodUl9jh1PcxSluKmxxijVOscUp1jiV71rCKXY4xQan2OH0ATp9t3-yd-CZA0G8Qp674aWlIDlPaUESHsRUxJwUNA45rQLwIuI4T2CoGFj4glVJLoTYgbuCJxEPAl4WPHqI1uumLh8jHFd5VAVUVGmQEkEo56QCVSZCFlIaBUUfETvYWWGq5ctDW84zGxZ5lhl2ZZJd2U6UAbv6yHdkE10u5jqCxHIysyMG2jsDeF5HyByhMZa1EXwT0hcWMhkoE7lDyOuymU-zMJSJ92Chxn30SEPIdcPCsI_oErjcA7JQ_fIv9fiLKlhvJsWTf6Z8irYWouIZWp-18_I5ulVczMbTdhut0RHbNjPtF4sEFcY |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Science+in+the+Heartland%3A+Exploring+determinants+of+offering+cancer+clinical+trials+in+rural-serving+community+urology+practices&rft.jtitle=Urologic+oncology&rft.au=Ellis%2C+Shellie+D.&rft.au=Geana%2C+Mugur&rft.au=Mackay%2C+Christine+B.&rft.au=Moon%2C+Deborah+J.&rft.date=2019-08-01&rft.issn=1078-1439&rft.eissn=1873-2496&rft.volume=37&rft.issue=8&rft.spage=529.e9&rft.epage=529.e18&rft_id=info:doi/10.1016%2Fj.urolonc.2019.03.004&rft_id=info%3Apmid%2F30935846&rft.externalDocID=PMC6661185 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-1439&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-1439&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-1439&client=summon |